Treatment of Experimental Neuroblastoma with Angiogenic Inhibitors
Neuroblastoma is a childhood cancer which arises from neuroblasts in the peripheral nervous system. Neuroblastoma show substantial heterogeneity regarding location, responsiveness to treatment and prognosis. Due to the fact current therapy requires drugs with likelihood of severe negative effects in the growing